Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Accord Healthcare in the EU, US, Canada, SA, Australia, APAC as well as CIS & MENA regions. Intas is present in 85+ countries, with more than 70% of its revenue coming from global business. Currently ranked 6th in the Indian pharmaceutical market, it’s the largest privately owned Indian generic pharma company. Intas has established leadership in key therapeutic segments like CNS, Cardio, Diabeto, Gastro, Urology, Oncology & Animal Health in India. We are among the top 10 generic players in the highly regulated markets of EU, US & UK. Intas operates 16 advanced formulations, R&D, and distribution facilities, of which 10 are in India and the rest in the UK, Mexico & Greece with the help of our 18,000+ Human Capital. Between them, the facilities are accredited by global regulators such as USFDA, EMA, MHRA, TGA, and others. The company invests ~6-7% of its revenues in R&D and has over 10,000 product registrations worldwide with a strategic pipeline of 300+ high-value FTF/FTM, Biosimilars, and NDDS products. Intas' highly advanced EU-GMP Certified Biopharma division is fueled by a mission to provide affordable “Biosimilars for Billions” across niche segments such as oncology, auto-immune, ophthalmology, nephrology, rheumatology, and hormone-based therapies. The Plasma Fractionation Unit of Intas Pharmaceuticals is a pioneer in manufacturing plasma-derived therapeutics. It houses a full-fledged R&D lab and a state-of-the-art WHO-GMP-certified manufacturing facility complemented with a GLP-compliant QC lab. Our values of Innovation, Customer Delight, Ownership & Collaboration, Performance Focus & Care for Society are the driving forces toward excellence.
View Top Employees from Intas PharmaceuticalsWebsite | https://intaspharma.com |
Revenue | $1.35 billion |
Funding | $106.3 million |
Employees | 14,497 (7,967 on RocketReach) |
Founded | 1976 |
Address | Sarkhej Gandhinagar Highway, Near Sola Bridge, Ahmedabad, Gujarat, IN |
Phone | +91 79 6157 7000 |
Fax | +91 79 2657 8862 |
Industry | Pharmaceutical Manufacturing, Manufacturing General, Biosimilars Development, Manufacturing, Recombinant Proteins Manufacturing |
Web Rank | 197718 |
Web Visits | 228590 |
Keywords | Drug Development And Manufacturing, Pharmaceuticals Company, Pharmaceuticals Pakistan, Pharmaceutical Development |
Competitors | Emcure Pharmaceuticals Limited, Glenmark Pharmaceuticals, J B Chems, LFB, Zhejiang Hisun Pharmaceutical Co., Ltd. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325413 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Intas Pharmaceuticals employee's phone or email?
The Intas Pharmaceuticals annual revenue was $1.35 billion in 2024.
Venugopal Vijayendran is the President: India - Marketing and Sales of Intas Pharmaceuticals.
7,967 people are employed at Intas Pharmaceuticals.
Intas Pharmaceuticals is based in Ahmedabad, Gujarat.
The NAICS codes for Intas Pharmaceuticals are [325413, 3254, 325, 32541, 32].
The SIC codes for Intas Pharmaceuticals are [283, 28].